Repositionable tissue traction devices

Repositionable tissue traction devices address the inefficiencies of existing tethered systems by enabling adjustable tension and clip removal, improving visibility and safety in endoscopic procedures.

WO2026241676A1PCT designated stage Publication Date: 2026-11-19BOSTON SCIENTIFIC SCIMED INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2026/028433
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-16
Filing Date
2026-05-15
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Endoscopic surgical procedures, particularly ESD, face challenges with inefficient tissue traction due to limited visibility and obstruction by partially dissected tissue, leading to increased procedure time and risk of complications like perforation or bleeding, as existing tethered systems fail to maintain or adjust tension effectively.

Method used

Repositionable tissue traction devices with repositionable clips that can be adjusted during the procedure to maintain optimal tension on target tissue, allowing for improved visibility and reduced procedural time, and are removable post-procedure to avoid foreign material retention.

Benefits of technology

Enhances visualization and operational efficiency, reduces procedure time, and minimizes complications by maintaining consistent tissue tension and allowing for clip removal post-procedure.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2026028433_19112026_PF_FP_ABST
    Figure US2026028433_19112026_PF_FP_ABST
Patent Text Reader

Abstract

The present disclosure relates generally to the field of medical devices. For example, a repositionable tissue traction device can comprise a first arm including a proximal end region and a distal end region, a second arm including a proximal end region and a distal end region, and a repositioning feature coupled to or integral with the proximal end regions of the first arm and the second arm, where the repositioning feature is actuatable to radially expand at least the distal end regions of the first arm and the second arm to an open configuration.
Need to check novelty before this filing date? Find Prior Art

Description

REPOSITIONABLE TISSUE TRACTION DEVICESCROSS REFERENCE TO RELATED APPLICATIONS

[0001] The present application claims the benefit of US Provisional Patent Application Serial No. 63 / 807,295, filed May 16, 2025, the disclosure of which is incorporated herein by reference.FIELD

[0002] The present disclosure relates to the field of medical devices. Specifically, the disclosure pertains to medical devices configured to provide tissue traction during endoscopic surgical procedures, such as endoscopic submucosal dissection (ESD) procedures.BACKGROUND

[0003] Surgical dissection of lesions from within narrow body passages, such as the digestive tract, may be inefficient and time-consuming due to poor target tissue visualization during the dissection procedure. This problem may be exacerbated during the procedure, as the partially dissected target tissue obstructs the working area to further decrease visibility and obstructs the dissection tools.

[0004] In open surgery, traction is applied typically using the non-dominant hand directly or through a surgical instrument (typically some kind of forceps). In laparoscopic surgery, traction is applied via tissue graspers introduced through one of the surgical ports, which provide access to the target body cavity or space. This can be done by the lead surgeon, assisting surgeon or scrub nurse.

[0005] In endoscopic surgery, however, there are not multiple portals for accessing the target surgical site, with only the endoscope providing both visualization and access. Although there are some endoscopes with two working channels, or devices that can attach to the outside of the endoscope to provide a secondary working channel, all of these access channels are either integral to the endoscope or run parallel to it, and therefore are directionally constrained, and limited in the degrees of freedom of movement and control that can be achieved when maneuvering other devices to the target surgical site.

[0006] Endoscopic surgical procedures enable minimally invasive treatment of various conditions within body passages, such as the gastrointestinal (GI) tract, by delivering specialized instruments through working channels of endoscopes to access and manipulate target tissues. Techniques like Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), and Pre-Oral Endoscopic Myotomy (POEM) allow for the en bloc resection of benignand early malignant lesions. Compared to open or laparoscopic surgery, these minimally invasive techniques typically offer faster recovery times but require precise tissue manipulation within confined anatomical spaces, necessitating a high degree of expertise.

[0007] ESD, in particular, is a minimally invasive procedure enabling en bloc resection of superficial GI tumors. It involves accessing and visualizing target tissue sites using an endoscope equipped with visualization capabilities, such as a light and / or camera. Through the endoscope's working channel, various medical instruments, including cutting devices, grasping tools, and tissue traction devices, are deployed to perform the dissection.

[0008] Tissue traction is critical during ESD procedures as it improves visualization of the submucosal layer, enabling accurate and efficient dissection. Maintaining proper tension on the target tissue during dissection is essential to enhance visibility and operational precision. However, surgical dissection within narrow body passages can be inefficient and timeconsuming due to limited visibility. As mentioned, this challenge is often exacerbated by partially dissected tissue obstructing the working area and dissection tools.

[0009] Existing traction methods include tethered systems that use permanent (i.e., nonremovable) endoscopic clips attached to external filaments to retract or immobilize target tissue. Although effective in some cases, these systems can be limited in their ability to maintain or adjust tension on the target tissue, particularly during the course of a medical procedure. For example, as a portion of a target tissue (e.g., lesion) is dissected the tensioning force imparted by a permanent clip (e.g., which is coupled to the proximal portion of the target tissue) on the remainder (e.g., a distal portion) of the target tissue may be reduced. Stated differently, the tension imparted by the permanent clips on the target tissue (e.g., which has not yet been dissected) is reduced as the dissected flap of tissue to which the permanent clip is coupled becomes larger (e.g., as dissection progresses throughout a medical procedure to remove the target tissue). This limitation may obstruct visibility and interfere with accessory tools, potentially increasing procedure time, complexity, and the risk of complications, such as perforation or bleeding.

[0010] It is with these challenges in mind that the present disclosure introduces improved medical devices designed to optimize tissue traction during endoscopic procedures, thereby enhancing visualization, operational efficiency, and / or patient safety.SUMMARY

[0011] This summary of the disclosure is given to aid understanding, and one of skill in the art will understand that each of the various aspects and features of the disclosure may advantageously be used separately in some instances, or in combination with other aspects and features of the disclosure in other instances. No limitation as to the scope of the claimed subject matter is intended by either the inclusion or non-inclusion of elements, components, or the like in this summary.

[0012] The present disclosure relates to the field of medical devices, specifically those configured to provide tissue traction during endoscopic surgical procedures. These devices enhance visualization and / or dissection of target tissues while mitigating obstruction of dissection tools.

[0013] Some current ESD procedures typically use Multi-loop Traction Devices (MLTD). The MLTD can be comprised of three connected rings e.g., which are each made of a linear biocompatible low-density polyethylene plastic. The MLTD can be delivered to the lesion site from the forceps channel of an endoscope. The MLTD is intended to be cut and removed by grasping one of the rings using biopsy forceps and pulling away. However, use of the MLTD presents several challenges or drawbacks. For instance, the MLTD loop can be prone to breaking (e.g., in vivo) when the MLTD loop gets caught in the proximal end of the jaw during opening and closing actions. The MLTD can be prone to falling off or otherwise becoming inadvertently dislodged off the distal end of an endoscopic device (e.g., the jaw) in vivo. The breakage and / or inadvertent dislodging of the MLTD can result in added time or difficulty such as requiring the introduction of a new MLTD device and prolonging the procedure. Moreover, even when the MLTD is successfully deployed in vivo, the clips used to attach the MLTD e.g., to healthy tissue must be left behind in the patient's body as they cannot be safely removed. Further, use of the MLTD can inherently result in poor visualization and / or inadequate tissue manipulation (e.g., as tensioning and / or location of the MLTD cannot be adjusted (e.g., cannot be repositioned or otherwise adjusted to vary tension imparted on a lesion or other target tissue coupled to the MLTD) once the MLTD is attached via the permanent clips or other attachment mechanism to tissue).

[0014] Accordingly, the present disclosure provides tissue traction devices which are disposed in vivo and impart one or more forces on target tissue to maintain the target tissue under traction during a medical procedure such as an ESD procedure. Notably, the clips herein are repositionable to permit a sufficient amount of tension to be imparted by the clips on target tissue (e.g., a lesion) during the course of the dissection. For instance, the tissue traction devices and methods herein can permit repositioning of the clips during a medical procedure (e.g., afterinitiating dissection of a lesion but prior to dissection of the entire lesion from a body lumen). As detailed herein, maintaining the target tissue such as a lesion under traction during a tissue dissection procedure (e.g., when dissecting tissue) can reduce complications, reduce an amount of time of the procedure, and / or improve visibility throughout the procedure as compared to other approaches such as those that employ a MLTD. Moreover, unlike other approaches such as those that employ a MLTD, the tissue traction devices and methods herein can remove the clips from the body lumen after completion of the medical procedure and thus avoid issues (e.g., leaving foreign matter such as the clips behind in vivo). Thus, the devices and methods herein can yield faster and safer procedures (e.g., ESD procedures), while also addressing the limitations of current approaches such as those that employ MLTD.

[0015] In an example, a repositionable tissue traction device may include a first arm having a proximal end region and a distal end region, a second arm having a proximal end region and a distal end region, and a repositioning feature that might be coupled to or integral with the proximal end regions of the first arm and the second arm, wherein the repositioning feature may be actuatable to radially expand at least the distal end regions of the first arm and the second arm to an open configuration.

[0016] Alternatively or additionally to any of the examples above, in another example, the repositioning feature might include an opening that may be configured to receive an actuation feature of an endoscope.

[0017] Alternatively or additionally to any of the examples above, in another example, the repositioning feature might comprise a loop.

[0018] Alternatively or additionally to any of the examples above, in another example, the repositioning feature may be integral with the first arm and the second arm.

[0019] Alternatively or additionally to any of the examples above, in another example, the proximal end regions of the first arm and the second arm together might form the repositioning feature.

[0020] Alternatively or additionally to any of the examples above, in another example, the repositioning feature may be coupled to the first arm and the second arm.

[0021] Alternatively or additionally to any of the examples above, in another example, the repositioning feature might extend through an opening formed in one or both of the proximal end regions, and a distal end of the repositioning feature may be positioned distal to the opening and might be tapered, and a proximal end of the repositioning feature may be a ring.

[0022] Alternatively or additionally to any of the examples above, in another example, the device might include a biasing rib extending between and coupled to the first arm and thesecond arm, wherein the biasing rib may be configured to disposition the first arm and the second arm to a closed configuration.

[0023] Alternatively or additionally to any of the examples above, in another example, the biasing rib might be arched.

[0024] Alternatively or additionally to any of the examples above, in another example, the first arm and the second arm may extend in a substantially longitudinal direction without an overlap between the first arm and the second arm.

[0025] Alternatively or additionally to any of the examples above, in another example, the first arm and the second arm might extend in a substantially longitudinal direction and may overlap at least once along a longitudinal length thereof.

[0026] Alternatively or additionally to any of the examples above, in another example, at least the first arm and the second arm may be formed of a shape memory material.

[0027] Alternatively or additionally to any of the examples above, in another example, the entire repositionable tissue traction device might be formed of shape memory material, stainless steel, a cobalt-chromium alloy, or any combination thereof.

[0028] Alternatively or additionally to any of the examples above, in another example, the device may include a suture feature located on the first arm, the second arm, the repositioning feature, or any combination thereof, wherein the suture feature might be a loop.

[0029] Alternatively or additionally to any of the examples above, in another example, the suture feature may be located on an exterior surface of the first arm, an exterior surface of the second arm, or both.

[0030] In an example, a repositionable tissue traction device might include a substantially longitudinally extending first arm having a proximal end region and a distal end region, a substantially longitudinally extending second arm having a proximal end region and a distal end region, and a repositioning feature that may be coupled to or integral with the proximal end regions of the first arm and the second arm, wherein the repositioning feature might be configured to move the repositionable tissue traction device from a closed configuration to an open configuration wherein the distal end regions may be radially expanded, wherein the first arm, the second arm, and the repositioning feature might be formed of a shape memory material.

[0031] Alternatively or additionally to any of the examples above, in another example, the shape memory material may be heat set to bias the repositionable tissue traction device to the closed configuration.

[0032] In an example, a system might include a repositionable tissue traction device comprising a substantially longitudinally extending first arm having a proximal end region and adistal end region, a substantially longitudinally extending second arm having a proximal end region and a distal end region, and a repositioning feature that may be coupled to or integral with the proximal end regions of the first arm and the second arm, wherein the repositioning feature might be configured to move the repositionable tissue traction device from a closed configuration wherein the distal end regions may be in a radially contracted configuration to an open configuration wherein the distal end regions might be in a radially expanded configuration, wherein at least the first arm and the second arm may be formed of a shape memory material, and an endoscope that might include an actuation member configured to be disposed within the repositioning feature and actuate the repositioning feature to move the repositionable tissue traction device from the closed configuration to the open configuration.

[0033] Alternatively or additionally to any of the examples above, in another example, the actuation member might be a hook.

[0034] Alternatively or additionally to any of the examples above, in another example, the hook may be rotatable about a longitudinal axis of the endoscope.BRIEF DESCRIPTION OF THE DRAWINGS

[0035] Non-limiting embodiments of the present disclosure are described by way of example with reference to the accompanying figures, which are schematic and not intended to be drawn to scale. In the figures, each identical or nearly identical component illustrated is typically represented by a single numeral. For purposes of clarity, not every component is labeled in every figure, nor is every component of each embodiment shown where illustration is not necessary to allow those of ordinary skill in the art to understand the disclosure. In the figures:

[0036] FIG. 1 A provides a perspective view of an example endoscope in a first configuration according to an embodiment of the present disclosure;

[0037] FIG. IB provides a perspective view of the example endoscope of FIG. 1 A in a second configuration;

[0038] FIG. 2 A provides a view of a portion of an example endoscope and an example of a repositionable tissue traction device in a first (closed) configuration;

[0039] FIG. 2B provides a view of the portion of the example endoscope and the example of the repositionable tissue traction device in a second (open) configuration;

[0040] FIG. 3 provides a view of another example of a repositionable tissue traction device;

[0041] FIG. 4 provides a view of another example of a repositionable tissue traction device;

[0042] FIG. 5 provides a view of another example of a repositionable tissue traction device;

[0043] FIG. 6 provides a view of another example of a repositionable tissue traction device;

[0044] FIG. 7 provides an example of a method of endoscopic tissue dissection according to an embodiment of the disclosure;

[0045] FIG. 8 illustrates an example deployment of repositionable traction devices;

[0046] FIG. 9A illustrates an example endoscopic tool; and

[0047] FIG. 9B is a magnified view of the distal end portion of the endoscopic tool shown in FIG. 9A.DETAILED DESCRIPTION

[0048] The present disclosure is not limited to the particular embodiments described herein. The terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting beyond the scope of the appended claims. Unless otherwise defined, all technical terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the disclosure belongs.

[0049] Although embodiments of the present disclosure are described with specific reference to endoscopic systems and methods designed to provide traction within the gastrointestinal tract during a tissue dissection / resection procedure, it should be appreciated that such systems and methods may be used to manipulate a variety of tissues within a variety of different body lumens and / or body passages in conjunction with or independent of an endoscope.

[0050] As used herein, the singular forms “a,” “an,” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprise”, “comprises”, and / or “comprising,” or “includes”, and / or “including” when used herein, specify the presence of stated features, regions, steps elements and / or components, but do not preclude the presence or addition of one or more other features, regions, integers, steps, operations, elements, components and / or groups thereof.

[0051] As used herein, the term “distal” refers to the end farthest away from the medical professional when introducing a device into a patient, while the term “proximal” refers to the end closest to the medical professional when introducing a device into a patient.

[0052] Referring to FIGS. 1 A-1B, an example of an endoscope 130 is provided. More specifically, FIG. 1 A provides a perspective view of an example endoscope 130 in a first (e.g., delivery) configuration with an actuation member 126 disposed within a lumen of the endoscope 130, while FIG. IB provides a perspective view of the example endoscope of FIG. 1 A in a second (e.g., deployed or longitudinally extended) configuration with the actuation member translated a distance distal of the distal end of the endoscope 130, as detailed herein.

[0053] The endoscope 130 can be positioned within the vasculature or a body cavity of a patient to facilitate various medical procedures such as those described herein. For instance, the endoscope 130 can be a duodenoscope that is configured for endoscopic submucosal dissection (ESD). For example, the endoscope 130 can be navigated within an esophagus of a patient to permit removal of target tissue (e.g., a lesion) located in the esophagus. In some instances, the target tissue can be a target lesion that is disposed in vivo.

[0054] As illustrated in FIGS. 1 A-1B, the endoscope 130 has a distal end 111 and a proximal end 113 opposite the distal end 111. The flexible elongate tubular member (e.g., endoscope 130) can have a working channel 114 extending between the proximal end 113 and the distal end 111. The working channel 114 represents one or more substantially longitudinally extending channels. For instance, the working channel 114 can have a substantially uniform diameter (e.g., 2.8 millimeters) taken along an entire length thereof. The working channel may include a sheath 115 including one or more uninterrupted lumens (e.g., that do not include any elements therein e.g., prior to a pull wire 116 being disposed in the one or more lumens).

[0055] In some embodiments, the one or more lumens can be substantially circular lumens having a smooth and uniform diameter surface. Employing circular lumens such as those with a smooth and uniform diameter surface (e.g., taken at any point longitudinally along a surface of the lumens) can promote aspects herein such as permitting the pull wire 116 and / or an actuation member 126 coupled to a distal end of the pull wire 116 to readily translate in a longitudinal manner and / or permitting rotation of the pull wire 116 and / or the actuation member 126. For instance, an actuation member 126 may be movably / slidably disposable within the working channel 114 and an individual lumen of the lumens.

[0056] For example, the pull wire 116 can be configured to translate in a substantially longitudinal manner responsive to actuation (e.g., longitudinal movement) of a spool 128. That is, the pull wire 116 and the actuation member 126 for use with an endoscope 130 of the present disclosure may include a spool 128 or other type of member or handle that is operatively attached to a proximal end of the pull wire 116. In some embodiments, the pull wire 116 and hence the actuation member 126 can be configured to rotate (e.g., about or relative to a longitudinal axis of the endoscope 130) responsive to actuation or movement of a rotating knob 129. For instance, the actuation member 126 can be configured to rotate 360 degrees about the longitudinal axis of the endoscope 130. Stated differently, the pull wires and the hooks herein are translatable along and rotatable about one or more longitudinal axis of the endoscopes herein. While a knob (the knob 129) and a spool (the spool 128) are illustrated, employing additional or alternate types of actuation mechanisms such as handles, levers, etc. is possible.

[0057] As illustrated in various figures herein, a portion of the pull wire 116 and the actuation member 126 may each be extendable distally beyond the distal end 111 of the endoscope 130, for instance, to permit the actuation member 126 to actuate a removable tissue tensioning device (not illustrated in Figs. 1 A-1B), as detailed herein. For instance, the distal tip of the actuation member 126 can be configured to translate longitudinally a first distance relative to the distal end 111 of the endoscope 130. The first distance may be in a range from about 2 millimeters to about 15 millimeters or from about 5 millimeters to about 15 millimeters, among other possible values. Permitting the actuation member 126 to move the first distance distal of the distal end 111 of the endoscope 130 and / or rotate about the longitudinal axis of the endoscope (e.g., while extended the first distance distal to the distal end 111 of the endoscope 130) can promote aspects herein such as permitting the actuation member 126 to readily be disposed within a repositioning feature of a repositionable tissue traction device and hence permit repositioning of the repositionable traction device.

[0058] In some embodiments, the actuation member 126 can be a hook or other member having at least a portion thereof configured at a non-zero angle (e.g., relative to the pull wire 116). The angle can be any angle in a range from about 5 degrees to about 130 degrees. All individual values and sub-ranges from about 5 degrees to about 130 degrees are included. For instance, the distal tip of the actuation member can be a hooked or arced distal tip, as illustrated in FIG. IB. Employing a hooked distal tip can promote aspects herein such as promoting the actuation member 126 to readily be located within and exert a force on the repositioning feature while the repositionable tissue traction device is disposed in vivo, as described herein.

[0059] In some embodiments, the actuation member 126 can be formed of a shape memory material such as those described herein. However, the use of other non-shape memory material such as stainless steel and / or a cobalt-chromium alloy is possible. In some embodiments, the pull wire 116 can be formed of a shape memory material. However, the use of other non-shape memory material is possible. In some embodiments, each of the pull wire 116 and the actuation member 126 can be formed of the same material (e.g., a shape memory or non-shape memory material such as stainless steel). For instance, the actuation member 126 can be integral with the pull wire 116. For example, the actuation member 126 and pull wire 116 can be formed of a shape memory material with at least the actuation member 126 being heat-set to a non-linear shape such as a hooked-shape, among other possibilities. However, in some embodiments, the pull wire 116 and the actuation member 126 can be formed of different materials. For example, the actuation member 126 can be coupled to the pull wire 116 in a nonmovable manner (e.g., welded, adhesively bonded, friction fit, etc.) such that the actuation member 126 does not move relative to the pull wire 116. Thus, any movement (e.g., translationand / or rotation) of the pull wire can impart a corresponding movement (e.g., in terms of magnitude and direction) of the actuation member 126. However, in some embodiments, the actuation member 126 can be configured to move (e.g., with at least one degree of freedom) relative to the pull wire 116.

[0060] In some embodiments, a coil 119 or other type of sheath can overlay (e.g., extend circumferentially about) at least a portion of the sheath 115. The coil 119 can be a helical (spiral) coil, a conical coil, or other type of coil. The coil 119 can be formed of stainless steel and / or another type of material. The presence of the coil 119 can promote aspects herein. For instance, the coil 119 can provide a degree of rigidity thereby easing navigation of the pull wire 116 and / or the actuation member 126 in vivo e.g., when the actuation member is disposed the first distance distal of the distal end 111 of the endoscope 130. Alternatively or additionally, the coil 119 can provide a rigid surface that is configured (e.g., shaped and sized) to contact the actuation member of a repositionable tissue traction device and thereby impart a force on the actuation member to cause the repositionable tissue traction member to move from a closed configuration to an open configuration as detailed herein (e.g., with respect to Figs. 2A-2B).

[0061] As mentioned, FIG. 1 A provides a perspective view of the example endoscope 130 in a first (e.g., initial) configuration e.g., when disposed in vivo in a patient with a target lesion (e.g., target tissue). FIG. IB provides a perspective view of the example endoscope 130 in a second configuration disposed in vivo in the patient with the target tissue. As mentioned, each of the pull wire 116 and the actuation member 126 can be configured to move (e.g., longitudinally translate) along the working channel of the endoscope 130. For instance, the actuation member (e.g., a hook) 126 can be translated distally via translation of the proximal spool 128. While a proximal spool 128 is illustrated, employing additional or alternate types of actuation mechanisms such as handles, levers, etc. is possible. Thus, the actuation member 126 can be moved from the first position, as illustrated in FIG. 1 A, to a second position that is distal to the first position, as illustrated in FIG. IB. When in the second position, the actuation member 126 can contact a repositioning member of a repositionable tissue traction device. For instance, a distal end (e.g., hooked portion) of the actuation member 126 can be disposed within a loop or other type repositioning feature and thus can permit removal or repositioning of the repositionable tissue traction device at a target site in vivo.

[0062] The repositionable traction devices described herein can have a longitudinal length in a range from about 5 millimeters to about 15 millimeters or about 8 millimeters to about 15 millimeters. The repositionable tissue traction devices herein can have a width (radial width) in a range from about 1.8 millimeters to about 2.2 millimeters. For instance, therepositionable traction devices herein can have a length of about 15 millimeters and a width of about 2.2 millimeters, among other possible values.

[0063] The repositionable traction devices described herein can be delivered through the endoscope 130 (e.g., through a working channel of the endoscope 130 when the pull wire 116 is removed, and another instrument, such as a delivery catheter, is present in the working channel), as is conventionally known. Alternatively, the repositionable traction devices can be delivered over-the-scope, also as is conventionally known. Another endoscope or a different tool, such as a catheter, can also be utilized to deliver the repositionable traction devices to a target site. In some instances, an individual repositionable tissue traction device can be delivered to the target site in vivo. Optionally, one or more additional repositionable traction devices can be delivered to the target site as well. In certain cases, multiple repositionable traction devices can be delivered to the target site simultaneously. For example, two repositionable traction devices may be delivered as a set through the working channel together in a bank or another type of component housing the set. In such instances, the repositionable traction devices within the set can be coupled to the target site (e.g., released individually from the bank), as described herein e.g., with respect to FIGS. 9A-9B. Additionally, one or more repositionable traction devices such as another set of two repositionable traction devices may be delivered subsequently.

[0064] The repositionable traction devices herein can be formed of one or more wires or filaments. For instance, at least a portion of the repositionable traction devices herein can be formed of a shape memory material such as nitinol, stainless steel, a cobalt-chromium alloy, or any combination thereof. In some embodiments, the entire repositionable tissue traction device can be formed of a shape memory material. The shape memory material can be heat set to bias the repositionable traction devices herein to a closed configuration, as detailed herein.

[0065] The repositionable traction devices herein can include a plurality of arms configured to engage with tissue at a target site in vivo. For instance, the repositionable traction devices herein can include two arms that are substantially the same longitudinal length and are the same shape. The arms can have the same profile (e.g., same radial profile) along an entire longitudinal length of the arms. For instance, the arms can be mirror-images or can have an inverted symmetry. In some embodiments, the arms do not overlap along a longitudinal length of the arms. Having an absence of any overlap along the longitudinal length of the arms can promote aspects herein. For instance, the absence of overlap can yield a substantially linear or uniform profile which can reduce a possibility of inadvertent contact of the arms with tissue, ease delivery of the repositionable traction device, simplify manufacture of the repositionable traction devices, etc.

[0066] However, in some embodiments, the arms can cross or overlap at least one point along a longitudinal length of the arms. The arms can cross or overlap at any point along the longitudinal length of the arms. For instance, arms can cross or overlap at the proximal end regions thereof (e.g., as illustrated in FIG. 5), at a midpoint or relatively central location thereof (e.g., as illustrated in FIG. 4), and / or at a distal end region thereof. Having the arms cross or overlap can promote aspects herein such as increasing a holding force imparted by the distal ends of the arms on tissue at a target site, promoting biasing of the repositionable traction devices herein to the closed configuration, and / or reducing or eliminating any reliance on a shape-memory material to provide the holding force and / or bias the repositionable tissue traction device to the closed configuration, etc.

[0067] The arms can include a first arm having a proximal end region and a distal end region and a second arm having a proximal end region and a distal end region. In some embodiments, the arms can be substantially longitudinally extending arms having a curved or angled distal end portion (e.g., with respect to another more proximal portion of the arms). The curved or angled distal end portion of each arm can be formed at complimentary angles or degrees of curvature, can be the same shape, and / or can be the same size. Having the distal end portion of each arm can be formed at complimentary angles or degrees of curvature, be the same shape, and / or be the same size can promote aspects herein. For instance, such a configuration may promote each of the arms to contact tissue at a target site in vivo with substantially the same amount of force and / or to permit the arms to release from the target tissue responsive to application of substantially the same amount of actuation force (e.g., imparted by an actuation member on a repositioning feature of a repositionable traction device).

[0068] The repositionable traction devices herein can be configured to move between a closed configuration and an open configuration. In the closed configuration, the arms can be in contact or can be spaced a first distance (axially) apart. In the open configuration, the arms can be spaced a distance apart e.g., can be spaced a second distance apart (axially) that is larger than the first distance. In some embodiments, repositionable traction devices herein can be biased to the closed configuration. For instance, in the absence of an actuation force (e.g., imparted by the actuation features described herein) the repositionable traction devices can remain in the closed configuration. However, responsive to application of the actuation force, the repositioning features can move (e.g., permit the arms to deflect or rotate axially away from a longitudinal axis of the endoscope) thereby reconfiguring the repositionable traction devices herein in the open configuration. In such instances, responsive to removal of the actuation force, the repositioning features can return to the closed configuration. The sequence of opening and closing the repositionable traction devices herein (by way of actuation of the repositioning features) can berepeated multiple times (e.g., prior to, during, and / or after performing an ESD procedure). For instance, the opening and closing of the repositionable traction devices herein to permit an initial placement of the devices herein at a target site, relocation of the devices herein at or proximate to, and / or removal of the repositionable traction devices subsequent to completion of the ESD procedure.

[0069] The repositioning feature can be coupled to or integral with the proximal end regions of the first arm and the second arm. In some embodiments, the repositioning feature is integral with the first arm and the second arm. For instance, as detailed herein with respect to the FIGS. 2A-2B and 3-5, the repositioning feature can be integral with the arms. In some embodiments, the proximal end regions of the first arm and the second arm together form the repositioning feature. Having the proximal end regions of the first arm and the second arm together form the repositioning feature can promote aspects herein such as promoting ease of manufacture, reducing the complexity, and / or mitigating a potential for a portion of the repositionable tissue traction device to become dislodged or broken (e.g., broken or separated in vivo).

[0070] However, in some embodiments, the repositioning feature can be coupled to the arms. For instance, the repositioning feature can be coupled to a proximal end region of one or both of the arms. For example, the repositioning feature can extend through an opening in a proximal end region of one or both of the arms (e.g., as illustrated in FIG. 6). In such embodiments, a distal end of the repositioning feature can be positioned distal to the opening and a proximal end of the repositioning feature can be proximal to the opening. The proximal end of the repositioning feature can be a ring or other closed geometric shape having an opening therein. Hence, the proximal end can be configured to receive an actuation member (e.g., a hook). The distal end can be coupled directly to the proximal end or can include an intermediate portion (e.g., which is shaped and sized to translate through the opening). The distal end can include a tapered (longitudinally tapered) portion which is at least partially located distal to the opening. The tapered portion can have a uniform or non-uniform taper. For instance, the tapered portion can have a uniform circumferential taper. The tapered portion can have a radial profile at a distal end that is larger than a radial profile at the proximal end. At least the radial profile at the distal end can be larger than a diameter of the opening in the one or more arm. Having the repositioning feature be coupled to the proximal ends of the arms can promote aspects herein. For instance, in such instances the repositioning feature may have one or more degrees of freedom with respect to the repositionable tissue traction device and thereby may ease coupling the actuation mechanism with the repositioning feature of the repositionable tissue traction device in vivo.

[0071] As mentioned, the repositioning feature is actuatable to radially expand at least the distal end regions of the first arm and the second arm to an open configuration. For instance, the repositioning features herein can be configured to receive an actuation feature of an endoscope. Hence, the repositioning features can include one or more openings that are configured to receive the actuation feature of an endoscope. The repositioning features herein can be circular, elliptical, tapered (e.g., tapered with a smaller radial profile at a proximal end than a radial profile at a distal end thereof), and / or can have various other shapes having at least one opening therein.

[0072] For instance, FIGS. 2A-2B illustrate an example of a portion of a sequence for removal from or repositioning of a repositionable tissue traction device. Specifically, FIG. 2A provides a view of a portion (distal end portion) of an example endoscope 130 and an example of a repositionable tissue traction device 240 in a first (closed) configuration, while FIG. 2B provides a view of the portion of the example endoscope 130 and the example of the repositionable tissue traction device 240 in a second (open) configuration. The endoscope 130 can be analogous to the endoscope described herein with respect to FIGS. 1 A-1B.

[0073] As illustrated in FIGS. 2A-2B, the repositionable tissue traction device 240 includes a first arm 242 and a second arm 246. The first arm 242 and the second arm 246 are substantially longitudinally extending arms having complimentary profiles (e.g., mirrored profiles relative to a longitudinal axis therebetween). The first arm 242 includes a proximal end region 244 and a distal end region 243. The second arm 246 includes a proximal end region 248 and a distal end region 247. The distal end regions 243, 247 are angled or tapered towards each other. As illustrated in FIG. 2A, the distal end regions 243, 247 can be spaced a distance apart when the repositionable tissue traction device 240 is in the closed configuration. However, in some embodiments, the distal end regions 243, 247 can be in contact (e.g., the respective distal tips thereof can be in contact) when the repositionable tissue traction device 240 is in the closed configuration.

[0074] As illustrated in FIGS. 2A-2B, the repositionable tissue traction device 240 includes a repositioning feature 250 formed by the proximal end regions 244, 248 of the arms 242, 246. Stated differently, the repositioning feature 250 can be integral with the arms 242, 246. The repositioning feature 250 is a closed loop (e.g., a substantially flat or planar loop) with an opening 251 disposed therein. As illustrated in FIGS. 2A-2B, the repositioning feature 250 is tapered (e.g., a substantially V-shaped feature with a smaller radial cross-section at a proximal end of the repositioning feature than a radial cross-section at the distal end of the repositioning feature.) Employing a tapered repositioning feature (e.g., a V-shaped repositioning feature) can promote actuating the repositionable tissue traction device from the closed configuration to theopen configuration, as detailed herein. However, other shapes of the repositioning feature are possible.

[0075] As illustrated in FIG. 2A, the actuation member 126 has been moved (e.g., translated) to a position within the opening 251 in the repositioning feature 250 of the repositionable tissue traction device 240. After the actuation member 126 is positioned within the opening 251, the actuation member 126, sheath 115, and the pull wire 116 can be moved proximally relative to a distal tip of the coil 119. For instance, the actuation member 126, sheath 115, and the pull wire 116 can be moved proximally until a proximal portion of the repositioning feature 250 is in contact with the distal end of the coil 119, as illustrated in FIG. 2B. Contact of the actuation member 126 with the coil 119 imparts a force on the repositioning feature 250 (e.g., causes radial deflection of the repositioning feature) that is translated to the arms 242, 246 of the repositionable tissue traction device 240. As a result, the distal end regions 243, 247 can move or deflect radially away from each other, thereby reconfiguring the repositionable tissue traction device 240 in an open configuration. When in the open configuration, the repositionable tissue traction device 240 can be repositioned in vivo (e.g., during an ESD procedure) or can be removed (e.g., subsequent to completion of the ESD procedure).

[0076] As illustrated in FIGS. 2A-2B, in some embodiments, the repositionable tissue traction device 240 includes a biasing rib 260. The biasing rib 260 can be coupled to each of the arms 242, 246. For instance, the biasing rib can be coupled to opposing inner surfaces of the arms 242, 246, as illustrated in FIGS. 2A-2B. The biasing rib 260 can be configured to disposition the first arm 242 and the second arm 246 to a closed configuration. For instance, the biasing rib 260 can be configured to have the ends thereof extend in a proximal direction and can have an arched central region located between the ends, as illustrated in FIGS. 2A-2B. The arched biasing rib 260 can be substantially C-shaped or can be substantially U-shaped, among other possible curved shapes. The biasing rib 260 can be formed of the same material (e.g., a shape memory material) or a different material than the arms 242, 246. For instance, each of the biasing rib 260 and the arms 242, 246 can be formed of a shape memory material such as nitinol, stainless steel, a cobalt-chromium alloy, or any combination thereof.

[0077] While an individual biasing rib 260 is illustrated in FIGS. 2A-2B, the repositionable tissue traction devices herein can include additional biasing ribs or can have an absence of a biasing rib.

[0078] For instance, FIG. 3 provides a view of another example of a repositionable tissue traction device 370. The repositionable tissue traction device 370 is similar to the repositionable tissue traction device 240. For instance, the repositionable tissue traction device 370 includes a first arm 342 and a second arm 346. The first arm 342 and the second arm 346 are substantiallylongitudinally extending arms having complimentary profiles (e.g., mirrored profiles relative to a longitudinal axis therebetween). The first arm 342 includes a proximal end region 344 and a distal end region 343. The second arm 346 includes a distal end region 347 and a proximal end region 348. The distal end regions 343, 347 are angled or tapered towards each other. As illustrated in FIG. 3, the distal end regions 343, 347 can be spaced a distance apart when the repositionable tissue traction device 370 is in the closed configuration. However, in some embodiments, the distal end regions 343, 347 can be in contact (e.g., the respective distal tips thereof can be in contact) when the repositionable tissue traction device 370 is in the closed configuration.

[0079] As illustrated in FIG. 3, the repositionable tissue traction device 370 includes a repositioning feature 350 formed by the proximal end regions 344, 348 of the arms 342, 346. Stated differently, the repositioning feature 350 can be integral with the arms 342, 346. The repositioning feature 350 is a closed loop (e.g., a substantially flat or planar loop) with an opening 351 disposed therein. As illustrated in FIG. 3, the repositioning feature 350 is tapered (e.g., having a substantially V-shaped proximal end with a smaller radial cross-section at the proximal end of the repositioning feature 350 than a radial cross-section at the distal end of the repositioning feature 350).

[0080] As illustrated in FIG. 3, the repositionable tissue traction device 370 includes a biasing rib 360. The biasing rib 360 can be coupled to each of the arms 342, 346. For instance, the biasing rib 360 can be coupled to opposing inner surfaces of the arms 342, 346, as illustrated in FIG. 3. The biasing rib 360 can be configured to disposition the first arm 342 and the second arm 346 to a closed configuration. For instance, the biasing rib 360 can be configured to have the ends thereof extend in a proximal direction and can be an arched substantially radially extending rib, as illustrated in FIG. 3. The biasing rib 360 can be formed of the same material (e.g., a shape memory material) or a different material than the arms 342, 346. For instance, each of the biasing rib 360 and the arms 342, 346 can be formed of a shape memory material such as nitinol, stainless steel, a cobalt-chromium alloy, or any combination thereof.

[0081] In some embodiments, the repositionable tissue traction devices herein can include a suture feature. The suture feature can be located on an arm and / or a repositioning feature of the repositionable tissue traction devices herein. For instance, the suture feature can be located on a first arm, a second arm, a repositioning feature, or any combination thereof. The suture feature can be a loop or ring with an opening (e.g., permitting a suture or filament to be coupled to the suture feature or permit a suture or filament to be extended therethrough). In some embodiments, the suture feature can be located on an exterior (radial most) surface of the first arm, an exterior surface of the second arm, or both. For instance, returning to FIG. 3, a suturefeature 372 can be located on a proximal end region of an arm (e.g., the proximal end region 344 of the first arm 342). The suture feature 372 can permit the repositionable tissue traction device 370 to be coupled to another repositionable tissue traction device, for instance, as described with respect to FIG. 8 herein.

[0082] FIG. 4 provides a view of another example of a repositionable tissue traction device 475. The repositionable tissue traction device 475 includes a first arm 442 and a second arm 446. The first arm 442 and the second arm 446 are substantially longitudinally extending arms having complimentary profiles (e.g., mirrored profiles relative to a longitudinal axis therebetween). The first arm 442 includes a distal end region 443 and a proximal end region 444. The second arm 446 includes a distal end region 447 and a proximal end region 448. The distal end regions 443, 447 are angled or tapered towards each other. As illustrated in FIG. 4, the distal end regions 443, 447 can be in contact or overlap when the repositionable tissue traction device 475 is in the closed configuration. The repositionable tissue traction device 475 does not include a biasing rib.

[0083] As illustrated in FIG. 4, the repositionable tissue traction device 475 includes a repositioning feature 450 formed by the proximal end regions 444, 448 of the arms 442, 446. Stated differently, the repositioning feature 450 can be integral with the arms 442, 446. The repositioning feature 450 is a closed loop (e.g., a substantially flat or planar loop) with an opening 451 disposed therein. As illustrated in FIG. 4, the repositioning feature 450 is tapered (e.g., having a substantially V-shaped proximal end with a smaller radial cross-section at the proximal end of the repositioning feature 450 than a radial cross-section at the distal end of the repositioning feature 450). The repositionable traction device 475 can be formed from nitinol, stainless steel, a cobalt-chromium alloy, or any combination thereof.

[0084] As illustrated in FIG. 4, the arms 442, 446 overlap. Specifically, the arms overlap at an intersection 474 between the first arm 442 and the second arm 446. The intersection is located substantially at a midpoint along a longitudinal length of the repositionable tissue traction device 475. However, other locations of the intersection of the arms is possible.

[0085] FIG. 5 provides a view of another example of a repositionable tissue traction device 577. The repositionable tissue traction device 577 includes a first arm 542 and a second arm 546. The first arm 542 and the second arm 546 are substantially longitudinally extending arms having complimentary profiles (e.g., mirrored profiles relative to a longitudinal axis therebetween). The first arm 542 includes a distal end region 543 and a proximal end region 544. The second arm 546 includes a distal end region 547 and a proximal end region 548. The distal end regions 543, 547 are angled or tapered towards each other. As illustrated in FIG. 5, the distalend regions 543, 547 can be in contact or overlap when the repositionable tissue traction device 577 is in the closed configuration.

[0086] As illustrated in FIG. 5, the repositionable tissue traction device 577 includes a repositioning feature 550 formed by the proximal end regions 544, 548 of the arms 542, 546. Stated differently, the repositioning feature 550 can be integral with the arms 542, 546. The repositioning feature 550 is a closed loop (e.g., a substantially flat or planar loop) with an opening 551 disposed therein. The repositionable tissue traction device 577 includes a biasing rib such as those described herein (e.g., biasing rib 360 as described in FIG. 3). The repositionable traction device 577 can be formed of nitinol, stainless steel, a cobalt-chromium alloy, or any combination thereof.

[0087] As illustrated in FIG. 5, the arms 542, 546 overlap. Specifically, the arms overlap at an intersection 574 between the first arm 542 and the second arm 546. The intersection 574 is located in the proximal end regions 544, 548 of the repositionable tissue traction device 577. However, other locations of the intersection of the arms is possible.

[0088] FIG. 6 provides a view of another example of a repositionable tissue traction device 678. The repositionable tissue traction device 678 includes a first arm 642 and a second arm 646. The first arm 642 and the second arm 646 are substantially longitudinally extending arms having complimentary profiles (e.g., mirrored profiles relative to a longitudinal axis therebetween). The first arm 642 includes a proximal end region 644 and a distal end region 643. The second arm 646 includes a distal end region 647 and a proximal end region 648. The distal end regions 643, 647 are angled or tapered towards each other. As illustrated in FIG. 6, the distal end regions 643, 647 can be in contact at one or more points (e.g., in contact as indicated by element 668 and in contact at the distal tips thereof, as illustrated in FIG. 6) or overlap when the repositionable tissue traction device 678 is in the closed configuration. As illustrated in FIG. 6, the repositionable tissue traction device 678 does not include a biasing rib. As illustrated in FIG.6, the arms 642, 646 do not overlap, although overlapping configurations are possible. The repositionable traction device 678 can be formed of nitinol, stainless steel, a cobalt-chromium alloy, or any combination thereof.

[0089] As illustrated in FIG. 6, the repositioning feature 650 can be coupled to the arms 642, 646. For instance, the repositioning feature 650 can be coupled to proximal end regions 644, 648 of each of the arms 642, 646. For example, the repositioning feature 650 can extend through an opening 669 in a proximal end region of one or both of the arms (e.g., as illustrated in FIG. 6). In such embodiments, a distal end 672 of the repositioning feature 650 can be positioned distal to the opening 669 and a proximal end 671 of the repositioning feature 650 can be located proximal to the opening 669.

[0090] The proximal end 671 of the repositioning feature 650 is ring-shaped, as illustrated in FIG. 6, or other closed geometric shape having an opening therein. Hence, the proximal end 671 can be configured to receive an actuation member (e.g., a hook).

[0091] The distal end 672 can be coupled directly to the proximal end of the arms or can include an intermediate portion 673 (e.g., which is shaped and sized to translate through the opening 669), as illustrated in FIG. 6. The distal end 672 can include a tapered (longitudinally tapered) portion which is at least partially located distal to the opening 669. The tapered portion can have a uniform or non-uniform taper. For instance, the tapered portion can have a uniform circumferential taper. The tapered portion can have a radial profile at a distal end thereof that is larger than a radial profile at the proximal end thereof. At least the radial profile at the distal end of the repositioning feature 650 can be larger than a diameter of the opening 669. Thus, a longitudinal (proximal) force imparted on the proximal end 671 of the repositioning feature 650 can translate the distal end 672 proximally and thereby cause the arms 642, 646 to move or deflect radially outward from each other to move the repositionable tissue traction device 678 from the closed configuration illustrated in FIG. 6 to an open configuration.

[0092] FIG. 7 provides an example of a method 700 of endoscopic submucosal dissection according to an embodiment of the disclosure. The method 700 can be employed with the endoscope such as those described herein. At 702, the method 700 can include inserting an endoscope in vivo to access a target lesion in a patient. For instance, the target lesion or target tissue can be located in an esophagus of a patient, as described herein.

[0093] At 704, the method 700 can include positioning a repositionable tissue traction device at the target site in vivo. For instance, the method 700 can include distally advancing a repositionable tissue traction device to the target site in vivo. As mentioned, the repositionable tissue traction device can be provided to a target site through a working channel of an endoscope as is conventionally known or alternatively can be delivered over-the-scope, also as is conventionally known. Once at the target site, the repositionable tissue traction device can be deployed to tissue. For instance, the repositionable tissue traction device can be biased to a closed position, as detailed herein. In such embodiments, the repositionable tissue traction device can be configured to automatically engage target tissue after being deployed (e.g., when moved distally out of a bank of repositionable traction devices and / or other type of structure such as a catheter housing and / or maintaining the repositionable tissue traction device in an open delivery configuration). Alternatively, in some embodiments, the repositionable traction devices herein can be configured in the closed configuration via manipulation from an instrument (e.g., inserted via a working channel of an endoscope).

[0094] In some embodiments, the method 700 can include coupling a suture or other type of filament to one or more repositionable traction devices. For instance, a suture or filament can be coupled to a suture feature on a first repositionable tissue traction device that is coupled to target tissue (e.g., a target lesion). Additionally, the suture or filament can be coupled to a second repositionable tissue traction device located elsewhere (e.g., on a surface of a lumen opposing the location of the target tissue). This suturing or use of a filament can utilize the working channel of an endoscope and / or can be performed in an over-the-scope manner, for instance, as described with respect to FIG. 8, among other possible techniques.

[0095] At 706, the method 700 includes performing a medical procedure. For instance, at least a portion of an ESD procedure to remove the target tissue can be performed. At least the portion of the target tissue can be removed with an endoscopic instrument which is delivered via the working channel of the endoscope to the target site.

[0096] At 708, the method 700 includes repositioning the repositionable tissue traction device. For instance, the repositionable tissue traction device can be moved from a closed configuration to an open configuration, as described herein (e.g., with respect to FIGS. 2A-2B). The repositionable tissue traction device can be repositioned prior to, during, and / or after completion of a medical procedure such as an ESD procedure, as described herein. For instance, a repositionable tissue traction device (e.g., located on an opposing wall of a lumen opposite target tissue) can desirably be located to a more proximal or distal position to maintain the target tissue under a sufficient degree tension, thereby imparting a sufficient degree of lift in the target tissue throughout a medical procedure. As mentioned, dissecting the target lesion under tension (e.g., imparted by two or more repositionable tissue tensioning devices that are coupled together) can promote aspects herein e.g., promoting visibility of the target lesion, mitigating inadvertent contact with healthy tissue surrounding the target lesion, and / or promoting removal of the entire target lesion, etc. Hence, the endoscopes, repositionable tissue traction devices, and methods of using the endoscopes and repositionable tissue traction devices herein can yield improved control over a degree of tension imparted in a target lesion (e.g., variable tensioning of a target lesion attributable at least in part to a movable longitudinal position of the repositionable tissue traction devices) and can ensure that the target lesion remains under tension prior to and during dissection by the cutting member of the endoscope, unlike previous approaches such as those that utilized clips and / or a MLTD.

[0097] Moreover, and unlike previous approaches such as those that employ MLTD and / or clips, the method 700 can include retracting the entire endoscope and all components associated with the method 700 subsequent to removal of the target lesion. For instance, the method 700 can include removal of each of the repositionable tissue traction devices from thepatient after completing dissection of the target lesion. Thus, the endoscopes and repositionable tissue traction devices herein and methods of use thereof (e.g., method 700) can result in the effective removal (dissection) of the target lesion, and yet leaves no foreign materials (e.g., clips or MLTD) in the patient after retracting the endoscope from the patient.

[0098] FIG. 8 illustrates an example deployment of repositionable traction devices. As illustrated in FIG. 8, two repositionable traction devices 370-1 and 370-2 can be deployed in vivo. The repositionable traction devices can be analogous to the repositionable tissue traction devices described herein such as the repositionable tissue traction device described with respect to FIG. 3. The repositionable traction devices can be deployed as described herein. For example, the repositionable traction devices can be deployed via an endoscope e.g., as described with respect to FIGS. 1 A-1B and / or via an endoscopic tool as described with respect to FIGS. 9A-9B.

[0099] As illustrated in FIG. 8, the first repositionable tissue traction device 370-1 can be coupled to target tissue 882 (e.g., a lesion) and the second repositionable tissue traction device 370-2 can be coupled to a tissue wall opposing the target tissue 882. A suture or filament 883 can be coupled to the first repositionable tissue traction device 370-1 (e.g., to a suture feature 372 thereof) and the suture or filament 883 can extend through a suture feature 372 of a second repositionable tissue traction device 370-2, as described herein. This configuration permits the suture or filament 883 to be maintained under tension during a medical procedure such as an ESD procedure. For instance, the suture or filament 883 can be moved proximally during the medical procedure to maintain the target tissue (e.g., a flap of target tissue) under tension and / or the second repositionable tissue traction device 370-2 can be repositioned (e.g., during an ESD procedure) to maintain the target tissue under tension. Hence, an amount of lifting force on the target tissue 882 can be maintained (e.g., by moving the suture or filament 883 proximally during a medical procedure).

[0100] For example, the first repositionable tissue traction device 370-1 can be coupled to target tissue 882 (e.g., a lesion) and the second repositionable tissue traction device 370-2 can be coupled to a tissue wall opposing the target tissue 882 using the endoscopes described herein e.g., with the endoscopic tool described with respect to FIGS. 9A-9B. A suture or filament 883 can be coupled to the first repositionable tissue traction device 370-1 (e.g., to a suture feature 372 thereof) and the suture or filament 883 can extend through a suture feature 372 of a second repositionable tissue traction device 370-2. As an example, the suture or filament 883 can be fed through the endoscope from the distal end and attached to the first repositionable tissue traction device 370-1. Subsequently, the second repositionable tissue traction device 370-2 can be passed distally over the suture or filament 883 and coupled to the tissue wall opposing the target tissue 882. Desirably, the suture or filament 883 can be moved proximally during the endoscopicmedical procedure performed with an endoscope to maintain the target tissue (e.g., a flap of target tissue) under tension and / or the second repositionable tissue traction device 370-2 can be repositioned to maintain the target tissue under tension, for instance, once a portion of the target tissue has been dissected. For instance, the second repositionable tissue traction device 370-2 can be repositioned (e.g., via actuation thereof by a hook or other type of actuation member, as described herein) proximally or distally during an ESD procedure relative to an initial position of the traction device prior to starting the ESD procedure.

[0101] FIG. 9A illustrates an example endoscopic tool 990, while FIG. 9B is a magnified view of the distal end portion 993 of the endoscopic tool 990 shown in FIG. 9A. The endoscopic tool 990 includes a bank 992 configured to hold two or more repositionable traction devices at the same time. As such, the endoscopic tool 990 includes two rotating knobs 129-1, 129-2, and two spools or handles 128-1, 128-2. The first rotating knob 129-1 and the first spool or handle 128-1 are coupled via a first pull wire (not illustrated) and a first actuation member (not illustrated) to a first repositionable tissue traction device 370-1. Similarly, the second rotating knob 129-2 and the second spool or handle 128-2 are coupled via a second pull wire (not illustrated) and a second actuation member (not illustrated) to a second repositionable tissue traction device 370-2. Desirably, the endoscopic tool 990 can permit the first repositionable tissue traction device 370-1 to be coupled to target tissue 882 (e.g., a lesion), while the second repositionable tissue traction device 370-2 can be coupled to a tissue wall opposing the target tissue 882 in a single pass (e.g., without removal of the endoscopic tool 990 from the patient). The first repositionable tissue traction device 370-1 and the second repositionable tissue traction device 370-2 can be any of the repositionable tissue traction devices described herein.

[0102] In various embodiments, the endoscopes and repositionable traction devices herein are single-use devices that are configured for an individual medical procedure with an individual patient. In various embodiments, the endoscopic instrument of the present disclosure is not limited to a tissue cutting element (e.g., electrocautery knife, etc.), but may include a variety of medical instruments configured to manipulate a target tissue (e.g., ablative elements, needles or syringes configured to inject agents into the target tissue, etc.). In addition, it should be appreciated that various elements herein such as the repositionable tissue traction devices and the endoscopic instrument of the present disclosure are not necessarily drawn to scale, but may be represented in a somewhat enlarged configuration to provide the requisite level of detail to understand and practice the embodiments of the present disclosure.

[0103] All of the devices and / or methods disclosed and claimed herein can be made and executed without undue experimentation in light of the present disclosure. While the devices and methods of this disclosure have been described in terms of preferred embodiments, it may beapparent to those of skill in the art that variations can be applied to the devices and / or methods and in the steps or in the sequence of steps of the method described herein without departing from the concept, spirit and scope of the disclosure. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the disclosure as defined by the appended claims.

Claims

WHAT IS CLAIMED IS:

1. A repositionable tissue traction device comprising:a first arm including a proximal end region and a distal end region;a second arm including a proximal end region and a distal end region; anda repositioning feature coupled to or integral with the proximal end regions of the first arm and the second arm, wherein the repositioning feature is actuatable to radially expand at least the distal end regions of the first arm and the second arm to an open configuration.

2. The repositionable tissue traction device of claim 1, wherein the repositioning feature includes an opening that is configured to receive an actuation feature of an endoscope.

3. The repositionable tissue traction device of any one of claims 1-2, wherein the repositioning feature comprises a loop.

4. The repositionable tissue traction device of any one of claims 1-2, wherein the repositioning feature is integral with the first arm and the second arm.

5. The repositionable tissue traction device of claim 4, wherein the proximal end regions of the first arm and the second arm together form the repositioning feature.

6. The repositionable tissue traction device of any one of claims 1-2, wherein the repositioning feature is coupled to the first arm and the second arm.

7. The repositionable tissue traction device of claim 6, wherein the repositioning feature extends through an opening formed in one or both of the proximal end regions, and wherein: a distal end of the repositioning feature is positioned distal to the opening and is tapered; anda proximal end of the repositioning feature is a ring.

8. The repositionable tissue traction device of any one of claims 1-5, further comprising a biasing rib extending between and coupled to the first arm and the second arm, wherein the biasing rib is configured to disposition the first arm and the second arm to a closed configuration.

9. The repositionable tissue traction device of claim 8, wherein the biasing rib is arched.

10. The repositionable tissue traction device of any one of claims 1-9, wherein the first arm and the second arm extend in a substantially longitudinal direction without an overlap between the first arm and the second arm.

11. The repositionable tissue traction device of any one of claims 1-9, wherein the first arm and the second arm extend in a substantially longitudinal direction and overlap at least once along a longitudinal length thereof.

12. The repositionable tissue traction device of any one of claims 1-11, wherein at least the first arm and the second arm are formed of a shape memory material.

13. The repositionable tissue traction device of any one of claims 1-11, wherein the entire repositionable tissue traction device is formed of a shape memory material, stainless steel, a cobalt-chromium alloy, or any combination thereof.

14. The repositionable tissue traction device of any one of claims 1-13, further comprising a suture feature located on the first arm, the second arm, the repositioning feature, or any combination thereof, wherein the suture feature is a loop.

15. The repositionable tissue traction device of claim 14, wherein the suture feature is located on an exterior surface of the first arm, an exterior surface of the second arm, or both.